Data / Form D filings / StemoniX, Inc.
StemoniX, Inc.: Form D filings
StemoniX, Inc., a biotechnology company in Maple Grove, MN, filed 10 Form D notices with the SEC between 2016 and 2020. The latest, on May 15, 2020, reports $100,000 sold of a $10.9 million offering to 3 investors.
Find out what StemoniX, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13300 67th Ave N, Maple Grove, MN, 55311
- Phone
- (612) 802-9299
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1663434
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2020 | New notice | $10,890,965 | $100,000 | $10,790,965 | 3 | May 4, 2020 | sec.gov |
| Oct 11, 2019 | New notice | $6,000,000 | $2,066,366 | $3,933,634 | 31 | Sep 27, 2019 | sec.gov |
| Aug 22, 2018 | New notice | $12,000,000 | $1,428,760 | $10,571,240 | 7 | Aug 8, 2018 | sec.gov |
| Jun 4, 2018 | Amendment | $6,000,000 | $4,930,000 | $1,070,000 | 64 | Oct 24, 2017 | sec.gov |
| Apr 2, 2018 | Amendment | $4,500,000 | $4,390,000 | $110,000 | 48 | Oct 24, 2017 | sec.gov |
| Sep 28, 2017 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Mar 13, 2017 | New notice | $6,000,000 | $2,412,489 | $3,587,511 | 16 | Feb 24, 2017 | sec.gov |
| Oct 3, 2016 | Amendment | $2,500,000 | $2,500,000 | $0 | 36 | Jul 22, 2016 | sec.gov |
| Jul 26, 2016 | New notice | $1,500,000 | $523,000 | $977,000 | 8 | Jul 22, 2016 | sec.gov |
| Jan 12, 2016 | New notice | $2,300,000 | $1,138,600 | $1,161,400 | 9 | Dec 29, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sriram Nadathur | Director | |
| Patrick O'Shaughnessy | Director | |
| Yung-Ping Yeh | Executive Officer, Director, Promoter | |
| Paul Hansen | Director | |
| Kevin Gunderson | Director | |
| Andrew LaFrence | Executive Officer, Promoter | |
| Robert Petcavich | Executive Officer, Director, Promoter |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of May 11, 2020 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what StemoniX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.